Sanjay Chanda, SVP, Drug Development at Anacor Pharmaceuticals, holds 28.23K shares in AN2 Therapeutics, Inc. (Ticker: ANTX), holds 29.09K shares in Anacor Pharmaceuticals (Ticker: ~ANAC).
What is the percentage of profitable transactions made by Sanjay Chanda?
The percentage of profitable transactions made by Sanjay Chanda is ―.
What is the average return per transaction made by Sanjay Chanda?
The average return per transaction made by Sanjay Chanda is ―.
What stocks does Sanjay Chanda hold?
Sanjay Chanda holds: ~ANAC, ANTX stocks.
What was Sanjay Chanda’s latest transaction?
Sanjay Chanda latest transaction was an Uninformative Buy of ―.
What was Sanjay Chanda's most profitable transaction?
Sanjay Chanda’s most profitable transaction was an Informative Buy of ~ANAC stock on December 22, 2014. The return on the trade was 210.40%.
What is Sanjay Chanda's role in Anacor Pharmaceuticals?
Sanjay Chanda's role in Anacor Pharmaceuticals is SVP, Drug Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.